Recent Faculty Publications

Faculty members of the Department of ObGyn & Women's Health take pride in not only their clinical and educational skills but also in their roles as leading scholars and researchers. 

Brasky TM, Felix AS, Cohn DE, McMeekin DS, Mutch DG, Creasman WT, Thaker PH, Walker JL, Moore RG, Lele SB, Guntupalli SR, Downs LS, Nagel CI, Boggess JF, Pearl ML, Ioffe OB, Park KJ, Ali S, Brinton LA. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. Journal of National Cancer Institute

Prendergast EN, Holzapfel M, Mueller JJ, Leitao MM Jr, Gunderson CC, Moore KN, Erickson BK, Leath CA 3rd, Diaz Moore ES, Cohen JG, Walsh CS. Three versus six cycles of adjuvant platinum-based chemotherapy in early-stage clear cell ovarian carcinoma - A multi-institutional cohort. Gynecology Oncology

Uppendahl L, Mullany SA, Winterhoff B. Molecular characterization of endometrial cancer and therapeutic implications. Current Opinions in Obstetrics and Gynecology

Dickson EL, Stockwell E, Geller MA, Vogel RI, Mullany SA, Ghebre R, Witherhoff BJ, Downs LS Jr, Carson LF, Teoh D, Glasgow M, Gerber M, Rivard C, Erickson BK, Hutchins J, Argenta PA. Enhanced Recovery Program and Length of Stay After Laparotomy on a Gynecologic Oncology Service: A Randomized Controlled Trial. Obstetrics and Gynecology

Argenta PA, Ballman KV, Geller MA, Carson LF, Ghebre R, Mullany SA, Teoh DG, Winterhoff BJ, Rivard CL, Erickson BK. The effect of photobiomodulation on chemotherapy-induced peripheral neuropathy: A randomized, sham-controlled clinical trial.Gynecology Oncology

Teoh D, Halloway RN, Heim J, Vogel RI, Rivard C. Evaluation of the American College of Surgeons National Surgical Quality Improvement Program Surgical Risk Calculator in Gynecologic Oncology Patients Undergoing Minimally Invasive Surgery.  Journal of Minimally Invasive Gynecology

Winterhoff B, Konecny GE. Targeting fibroblast growth factor pathways in endometrial cancer. Current Problems in Cancer

LeSage MG, Staley M, Muelken P, Smethells JR, Stepanov I, Vogel RI, Pentel PR, Harris AC. Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats. Drug & Alcohol Dependence

Allen A, Vogel RI, Meier E, Anderson A, Jensen J, Severson HH, Hatsukami D. Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers. Drug & Alcohol Dependence

Law EK, Sieuwerts AM, LaPara K, Leonard B, Starrett GJ, Molan AM, Temiz NA, Vogel RI, Meijer-van Gelder ME, Sweep FC, Span PN, Foekens JA, Martens JW, Yee D, Harris RS. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer. Science Advances

Landers EE, Erickson BK, Bae S, Huh WK. Trends in Colposcopy Volume: Where Do We Go From Here? Journal of Lower Genital Tract Diseases

Heinrich D, Vogel RI, Kozhimannil KB. Early elective delivery and vaginal birth after cesarean in rural US maternity hospitals. Rural Remote Health

Rizzardi AE, Zhang X, Vogel RI, Kolb S, Geybels MS, Leung YK, Henriksen JC, Ho SM, Kwak J, Stanford JL, Schmechel SC. Quantitative comparison and reproducibility of pathologist scoring and digital image analysis of estrogen receptor β2 immunohistochemistry in prostate cancer. Diagnostic Pathology

Smith HJ, Leath CA 3rd, Huh WK, Erickson BK. See-and-Treat for High-Grade Cytology: Do Young Women Have Different Rates of High-Grade Histology? Journal of Lower Genital Tract Disease

Randall TC, Goodman A, Schmeler K, Durfee J, Pareja R, Munkarah A, Rulisa S, Ghebre R, Trimble EL, Chuang L. Cancer and the world's poor: What's a gynecologic cancer specialist to do? Gynecology Oncology

Khan F, Vogel RI, Diep GK, Tuttle TM, Lou E. Prognostic factors for survival in advanced appendiceal cancers. Cancer Biomarkers

Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecology Oncology

Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecology Oncology